Drug reference
Amivantamab
Amivantamab is a medicine in the class oncology. It is used for non-small cell lung cancer.
- Drug class: Oncology
- Used for: non-small cell lung cancer
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to open the full Amivantamab monograph: doses, pregnancy and breastfeeding, side effects, warnings and every interaction.
- Mechanism of action
- Usual adult dose (summary)
- Pregnancy
- Breastfeeding
- Common side effects
- Precautions
- Known interactions
- Renal and hepatic dose adjustments
- How to give it
- Pharmacokinetics
- Patient counselling points
- IV preparation and dilution
Free 14-day trial. No card needed.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
